Skip to main content

Table 3 Effect of SFC therapy on the levels of cytokines in the induced sputum of COPD

From: Relationship between the anti-inflammatory properties of salmeterol/fluticasone and the expression of CD4+CD25+Foxp3+regulatory T cells in COPD

 

Baseline

SFC therapy

IL-17A (ng/ml)

0.40 ± 0.02

0.33 ± 0.03*

TNF-α (pg/ml)

802.71 ± 42.63

562.79 ± 29.76***

IL-8 (ng/ml)

43.09 ± 4.63

25.69 ± 3.50***

IL-10 (pg/ml)

39.09 ± 3.75

44.94 ± 4.92

  1. * p < 0.05, *** p < 0.001